ECHOSENS: AN INVOLVED AND ENGAGED COMPANY

Partnership

The EchoSens development model is based on innovation and on a vision of socially aware entrepreneurship. The mindset of the company means that on a daily basis EchoSens is an active partner in the most innovative projects in international research but is also involved in the social and environmental domains through various partnerships, in order to reply to the therapeutic challenges in the area of hepatogastroenterology. To nourish its innovation, EchoSens is involved in numerous partnerships.

Research Partnerships

EchoSens has privileged relationships with certain actors in the academic market as well as with industry in the sectors of ultrasound and other areas of advanced technology. So many domains to explore in order to respond to the therapeutic challenges of tomorrow.

• With the LUSSI (Laboratory of Ultrasound Signals and Instrumentation of the University of Tours), for the tuning or improvement of measurement systems or imagery by ultrasound,
• With the CEA LETI (Laboratory of Electronics and Information Technology ) and the University Louis Pasteur (ULP) of Strasbourg,
• With the international research and development project “TENIU” (Treatment and Non-Invasive Elastography by Ultrasound), in collaboration with the company Théraclion.

Clinical Partnerships

EchoSens is at the service of all actors in the world of hepatology in order to help therapeutic advances progress.

• With the Roche Laboratories in a clinical research partnership on Hepatitis C in hospitals and with practicing doctors,
• With Pfizer Laboratories for the putting in place of a programme of clinical research,li>
• With the Schering Plough laboratories for screening programmes in centres specialised in treating drug addicts,
• With the Abbott Laboratories, in Spain, in the framework of clinical research programmes on co-infections,
• With the BMS Laboratories on Hepatitis B.

Insititutional Partnerships

EchoSens develops partnerships by day after day building transversal relationships. They are carried out with laboratories, sources of technological innovation, as well as with associations of patients, the representatives of people affected by the illness.

• With the Bio CRITT (Regional Centre of Innovation and the Transfer of Biomedical Technology) whose vocation is to promote innovation in companies in the biomedical sector through the transfer of technology,
• With the associations of patients and doctors in France and abroad such as CREGG (Think Tank of the cabinets of the Hepatogastroenterology group, the AFEF (French Association for Studies of the Liver), SOS Hepatitis and the Belgian association CHAC (Hepatitis Crossroads - Help and Contact).li>